What drove AYA.AX stock higher today?

AYA.AX stock rose to **A$4.15** on 23 Jan 2026 after intraday buying near the **A$3.87** low. The move reflected renewed interest in Artrya's AI diagnostics and technical momentum, not a major company announcement.

What is Meyka AI's price forecast for AYA.AX stock?

Meyka AI's forecast model projects **A$7.30** for AYA.AX stock in 12 months, implying **75.96%** upside from **A$4.15**. Forecasts are model-based projections and not guarantees.

Is AYA.AX a buy, hold or sell?

Meyka AI rates AYA.AX **C+** with a **HOLD** suggestion. The grade balances the AI growth case against negative EPS, high valuation, and adoption risk. This is informational, not financial advice.

When is Artrya's next earnings report?

Artrya's next earnings announcement is scheduled for **2026-02-24**. Investors should watch revenue trends and any commentary on Salix adoption and recurring revenue.

AU Stocks

AYA.AX Artrya (ASX) closed A$4.15 23 Jan 2026: AI diagnostics could lift value

ByHuzaifa Zahoor January 23, 2026January 23, 2026

AYA.AX stock closed at A$4.15 on the ASX on 23 Jan 2026 after a 3.49% intraday rise, signalling renewed investor interest in Artrya Limited’s AI-driven cardiac imaging. The move followed a bounce from the day low of A$3.87 and sits below the 52-week high of A$5.24. Trading volume was 342,272 shares, below the 50-day average of 871,023, showing selective buying. We examine financials, technicals, Meyka forecasts, and the AI growth case that could shape the stock’s near-term outlook.